Results
1 -
10 of
31Resistance to crizotinib and therapeutic options, Guide to Targeted Therapies: Treatment Resistance in Lung Cancer HSP90 Inhibitor-Based Strategies for Cancer Therapy: Advancing Toward Clinical Impact, Heat Shock Protein-Based Therapies Detecting the Potential Pharmacological Synergy of Drug Combination by Viability Assays In Vitro, Chaperones Clinical Evaluation and Biomarker Profiling of Hsp90 Inhibitors, Chaperones Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer, Journal of Molecular Medicine The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer, Targeted Oncology Erratum to: Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1?? and STAT-3, Angiogenesis HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome, Oncogene Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells, Cell Death & Disease